Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors
{{output}}
Background: Immune checkpoint inhibitors (ICI), alone or in combination with other agents, are now standard of care for a range of tumour types, including breast cancer. Radiological assessment of baseline tumour burden has been ... ...
